These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2934264)

  • 21. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
    Lahlou S
    Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral effects of metoclopramide and domperidone in normal subjects and in hypertensive patients.
    Bernini GP; Lucarini AR; Franchi F; Salvetti A
    J Endocrinol Invest; 1988 Nov; 11(10):711-6. PubMed ID: 2852692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of dopamine type-2 receptor blockade on autonomic modulation.
    Kaya D; Ellidokuz E; Onrat E; Ellidokuz H; Celik A; Kilit C
    Clin Auton Res; 2003 Aug; 13(4):275-80. PubMed ID: 12955552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metoclopramide, domperidone and dopamine in man: actions and interactions.
    MacDonald TM
    Eur J Clin Pharmacol; 1991; 40(3):225-30. PubMed ID: 2060557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparate effects of acute administration of dopamine receptor antagonists on plasma aldosterone and prolactin levels in the rat.
    Van der Niepen P; Dupont AG; Buydens P; Smitz JJ; Vanhaelst L
    Horm Metab Res; 1987 Jun; 19(6):279-80. PubMed ID: 3305273
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
    Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma free and sulfoconjugated dopamine in man: relationship to sympathetic activity, adrenal function and meals.
    Eldrup E; Hagen C; Christensen NJ; Olgaard K
    Dan Med Bull; 1988 Jun; 35(3):291-4. PubMed ID: 3168558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma prolactin levels after acute and subchronic oral administration of domperidone and of metoclopramide: a cross-over study in healthy volunteers.
    Brouwers JR; Assies J; Wiersinga WM; Huizing G; Tytgat GN
    Clin Endocrinol (Oxf); 1980 May; 12(5):435-40. PubMed ID: 7428183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociated response of thyrotropin and prolactin to dopamine receptor blockade with domperidone in hypothyroid subjects.
    Marcondes JA; Santomauro AT; Minanni SL; Wajchenberg BL
    Horm Metab Res; 1991 Dec; 23(12):605-8. PubMed ID: 1778595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of corticosteroid secretion by dopaminergic mechanisms in rhesus monkeys.
    Sowers JR
    Am J Physiol; 1982 Nov; 243(5):E375-9. PubMed ID: 7137342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pressor responsiveness to intravenous quinpirole is blunted in malnourished, conscious rats: central vs. peripheral and spinal mechanisms.
    Lahlou S; Interaminense Lde F; Figueiredo AF; Duarte GP
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):16-25. PubMed ID: 15175553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of S(-) and R(+) sulpiride, metoclopramide, cisapride and domperidone on the small intestine suggest DA2-receptors are involved in the control of small intestinal transit time in rats.
    Zuccato E; Bertolo C; Salomoni M; Forgione A; Mussini E
    Pharmacol Res; 1992 Sep; 26(2):179-85. PubMed ID: 1409258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of bromocriptine on plasma catecholamines in normal men.
    Van Loon GR; Sole MJ; Bain J; Ruse JL
    Neuroendocrinology; 1979; 28(6):425-34. PubMed ID: 460538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in rats.
    Barrett RJ; Wright KF; Taylor DR; Proakis AG
    Life Sci; 1987 Apr; 40(15):1499-506. PubMed ID: 2951574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role for endogenous dopamine in modulating sympathetic-adrenal activity in humans.
    Mannelli M; Pupilli C; Lanzillotti R; Ianni L; Bellini F; Sergio M
    Hypertens Res; 1995 Jun; 18 Suppl 1():S79-86. PubMed ID: 8529079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers.
    Daul A; Elter-Schulz M; Poller U; Jockenhövel F; Pönicke K; Boomsma F; Man in't Veld AJ; Schäfes RF; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):429-37. PubMed ID: 8532072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa.
    Worth DP; Harvey JN; Brown J; Worral A; Lee MR
    Br J Clin Pharmacol; 1986 May; 21(5):497-502. PubMed ID: 3087398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine modulation of pathological human chromaffin tissue.
    Mannelli M; Pupilli C; Lanzillotti R; Ianni L; Amenta F; Ricci A; Serio M
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):22S-24S. PubMed ID: 2143384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the role of dopamine receptors in aldosterone secretion.
    Frisina N; Buemi M; Macri' I
    Ann Endocrinol (Paris); 1984; 45(6):387-91. PubMed ID: 6100228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective antagonism of the hypotensive effects of dopamine agonists in spontaneously hypertensive rats.
    McCoy CE; Douglas FL; Goldberg LI
    Hypertension; 1986 Apr; 8(4):298-302. PubMed ID: 2870024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.